The human genome is the ultimate code of the universe, and Genoox makes it much more accessible and actionable. According to various estimates, over 1 billion individuals will have their genomes sequenced between 2028 and 2030.
Today, critical genomic information is scattered throughout the entire value chain, which inhibits the vast potential of genetics to improve our lives.
Powered by artificial intelligence technology and a strong big data team, Genoox removes the barrier to widespread adoption and enables endless new use cases.
Genoox’s main product, Franklin (which can be described as the “Google of genetics”), is increasingly becoming the industry standard for genetics interpretation, recommendations, and data management.
We are big believers in the company’s future and look forward to our fruitful cooperation.
